“Genetic Polymorphism in CYP2D6 and Its Association With the Safety and Efficacy of Fluvoxamine in Patients With Major Depressive Disorder ”. 2023. Precision Medicine Communications 3 (1): 43-49. https://doi.org/10.55627/pmc.003.01.0301.